149 related articles for article (PubMed ID: 2427820)
1. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria.
Lillie C; Kobinger W
J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820
[TBL] [Abstract][Full Text] [Related]
2. A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
Furukawa Y; Takayama S; Sawaki S; Inoue Y; Chiba S
J Pharmacol Exp Ther; 1993 May; 265(2):801-6. PubMed ID: 8496825
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
Kobinger W; Lillie C
Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
[TBL] [Abstract][Full Text] [Related]
4. Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulation.
Lillie C; Kobinger W
J Cardiovasc Pharmacol; 1983; 5(6):1048-51. PubMed ID: 6196553
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
Gout B; Jean J; Bril A
J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735
[TBL] [Abstract][Full Text] [Related]
6. Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs.
Riley DC; Gross GJ; Kampine JP; Warltier DC
Anesthesiology; 1987 Nov; 67(5):707-16. PubMed ID: 3674471
[TBL] [Abstract][Full Text] [Related]
7. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
[TBL] [Abstract][Full Text] [Related]
9. Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on guinea pig sinoatrial node and ventricular action potentials.
Briggs I; BoSmith RE; Heapy CG
J Cardiovasc Pharmacol; 1994 Sep; 24(3):380-7. PubMed ID: 7528293
[TBL] [Abstract][Full Text] [Related]
10. [Underlying mechanisms of inotropic effects mediated by alpha-adrenoceptors in mammalian left atria--influences of stimulation frequencies and Ca++ channel blocking agents--].
Hattori Y
Hokkaido Igaku Zasshi; 1982 Jul; 57(4):437-55. PubMed ID: 6293951
[TBL] [Abstract][Full Text] [Related]
11. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
Temma K; Akera T; Brody TM; Rech RH
J Pharmacol Exp Ther; 1983 Sep; 226(3):885-92. PubMed ID: 6887016
[TBL] [Abstract][Full Text] [Related]
12. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.
Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H
J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49.
Thollon C; Cambarrat C; Vian J; Prost JF; Peglion JL; Vilaine JP
Br J Pharmacol; 1994 May; 112(1):37-42. PubMed ID: 8032660
[TBL] [Abstract][Full Text] [Related]
14. Interaction between histamine and clonidine in isolated guinea-pig atria.
Rubio E; Esplugues J; Morales-Olivas FJ; Morcillo E
J Pharmacol; 1982; 13(2):299-305. PubMed ID: 7098488
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
Krumpl G; Winkler M; Schneider W; Raberger G
Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
18. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
Dämmgen JW; Lamping KA; Gross GJ
J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
